Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
Platz
K P
KP
Department of Surgery, Virchow Clinic, Humboldt University, Berlin, Germany.
Mueller
A R
AR
Willimski
C
C
Mansoorian
B
B
Berg
T
T
Neuhaus
R
R
Hopf
U
U
Lobeck
H
H
Neuhaus
P
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D006084:Graft Rejection / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D008775:Methylprednisolone / Q000627:therapeutic use; D016853:Muromonab-CD3 / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015375:Receptors, Interleukin-2 / Q000276:immunology; D012008:Recurrence; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; C079843:inolimomab; D009173:Mycophenolic Acid; D016559:Tacrolimus; D008775:Methylprednisolone